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Background: Several studies have assessed the associations between migraine and underweight, pre-obesity or
obesity, with conflicting results. To assess the consistency of the data on the topic, we performed a systematic review
and meta-analysis of the available observational studies.
Methods: Multiple electronic databases were systematically searched up to October 2014 for studies assessing the
association between migraine and body mass index categories (underweight, pre-obesity, or obesity).
Results: Out of 2,022 records, we included 15 studies. When considering the 11 studies following the World Health
Organization BMI cutoffs, we found an increased risk of having migraine in underweight subjects (pooled adjusted
effect estimate [PAEE] 1.21; 95% CI, 1.07-1.37; P = 0.002) and in obese women (PAEE 1.44; 95% CI, 1.05-1.97; P = 0.023) as
compared with normal weight subjects; additionally, pre-obese subjects had an increased risk of having chronic migraine
(PAEE 1.39; 95% CI, 1.13-1.71; P = 0.002). When considering all the 15 studies, we additionally found an increased risk of
having migraine in obese as compared with normal weight subjects (PAEE 1.14; 95% CI, 1.02-1.27; P = 0.017); additionally,
obese subjects had an increased risk of having chronic migraine (PAEE 1.75; 95% CI, 1.33-2.29; P < 0.001). The pooled
analysis did not indicate an increased risk of having migraine in pre-obese subjects.
Conclusions: The meta-analysis of the available observational studies suggested an association between migraine and
obesity likely mediated by gender and migraine frequency. Further studies taking into account gender, migraine type,
frequency, activity, and duration could provide more robust evidence.
Keywords: Migraine; Obesity; Body mass indexBackground
Migraine has a prevalence of about 11% in the general
population and is the seventh most disabling disease
worldwide [1,2]. Obesity has had an increasing preva-
lence in recent decades and is associated with estab-
lished health risks and increased mortality [3]. While a
large number of epidemiological studies have investigated
the association between migraine and obesity [4,5], their
conflicting results have hindered any definite conclusion
about a possible increased risk of having migraine for
obese subjects or a possible increased risk of being obese
in the presence of migraine. Obesity has, however, been
found to be associated with high headache frequency [6]* Correspondence: simona.sacco@yahoo.com
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reproduction in any medium, provided the origand to be involved in the transformation of migraine from
episodic to chronic [7]. The relationship between migraine
and obesity is complex and still unclear, as the two condi-
tions share some pathogenic determinants and may influ-
ence one another [6].
In order to clarify and quantitatively reappraise the
epidemiological evidence of any link between migraine
and body mass index (BMI) categories, we performed a
meta-analysis of the available observational studies.Methods
The present meta-analysis was performed according to
the PRISMA guidelines [8].This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
inal work is properly credited.
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We included in the analysis published studies meeting
all the following predetermined criteria: 1) any migraine
or chronic migraine as outcome variables, and under-
weight, pre-obesity, or obesity as compared with normal
weight range as exposure variables, or vice versa; 2) an
observational design; 3) a clearly reported, unequivocal
definition of exposure and outcome variables (migraine,
chronic migraine, underweight, overweight, pre-obesity,
obesity); 4) an adjusted statistical model or a matching
procedure to control for potential confounders; 5) the
report of effect estimates with 95% confidence intervals
(CIs); and 6) English language. Therefore, we excluded
studies: 1) investigating non-migraine headaches; 2) con-
sidering BMI values as a matching factor in case-control
studies and not as a variable in their statistical model; 3)
comparing mean BMI values without providing effect es-
timates for BMI categories; 4) with an interventional de-
sign (such as randomized controlled trials), case reports,
and case series; 5) including only subjects with migraine,
only overweight or obese subjects, or only subjects with
metabolic syndrome; 6) reporting only abstracts and un-
published material; or 7) not published in English. We
also excluded from the analyses studies performed in
children and adolescents, because of the potential bias
due to the lower prevalence and more balanced gender
distribution of migraine in those age groups as com-
pared with adults [1].
Information sources and search strategy
Two investigators (PR and RO) independently searched
papers indexed in PubMed, Science Citation Index, and
Scopus from the beginning of indexing to October 31,
2014 and containing the terms “migraine”, “headache”, or
“headache disorder” combined with the terms “obesity”,
“overweight”, “body fat”, “body mass index”, or “waist cir-
cumference”. Filters for English language were applied. In
PubMed, the terms were searched as both text words and
Medical Subject Heading (MeSH) terms. A manual search
among references of selected articles and reviews was also
performed (PR and RO).
Study selection and data collection
In the review process we followed a two-step procedure.
In the first step, two investigators (CT and DD) inde-
pendently reviewed titles and abstracts of the potentially
eligible papers. In the second step, the same investigators
(CT and DD) independently reviewed the full-text version
of the selected articles and performed the manual search
of the references. In both steps, all disagreements were re-
solved by consensus among all the researchers.
A standardized form was used for data extraction, in-
cluding the following items: first author, year of the
study, country where the study was performed, studydesign and cohort, period of subject enrollment, age
range, gender distribution, exposures, outcomes, number
of migraineurs and of underweight, pre-obese, and obese
subjects according to BMI categories, type of effect esti-
mate, and confounders assessed.
Assessment of the risk of bias in individual studies
To ascertain the quality of eligible studies, we applied
the criteria of the Newcastle-Ottawa Scale for observa-
tional studies [9] with modified criteria for cross-
sectional studies [10]. We considered the risk of bias as
low, medium, or high if the included studies did not ful-
fill one, two, or three of those criteria, respectively.
Statistical analysis
We used odds ratios (ORs) and hazard ratios (HRs) to
estimate effect size. We chose to pool the adjusted effect
measures rather than the crude ones because of the role
of confounding factors on the validity of observational
studies. When different adjusted models were available,
we chose the model including the largest number of fac-
tors. We performed an overall analysis of the association
between the selected exposure and outcome variables.
Where possible, we also performed subgroup analyses
for gender. We assessed the association between mi-
graine and BMI categories, performing separate analyses
for the studies regarding migraine as the outcome and
BMI categories as the exposure and for the studies re-
garding BMI categories as the outcome and migraine as
the exposure. To obtain the pooled adjusted effect esti-
mate (PAEE), the natural logarithm of each single esti-
mate was weighted by the inverse of its variance. We ran
a random effects model [11] rather than a fixed effects
one because of the high likelihood of between-study
variance. To reduce methodological heterogeneity we
performed our primary analyses including only the stud-
ies which defined BMI categories according to the
World Health Organization (WHO) criteria for Western
populations (underweight, <18.50 kg/m2; normal range,
18.50 - 24.99 kg/m2; overweight, ≥25.00 kg/m2; pre-
obesity, 25.00 - 29.99 kg/m2; obesity, ≥30.00 kg/m2) [12].
Together with those primary analyses performed with
narrow inclusion criteria, we performed additional ana-
lyses with broad inclusion criteria including studies with
BMI cutoffs other than those of the WHO. When per-
forming analyses including the studies fulfilling broad
criteria, we considered the mid-points of BMI categories
as moderators in the statistical models in order to cor-
rect for the different cutoffs. We also performed a linear
analysis by transforming category-specific risk estimates
into estimates of the effect size associated with every 5
kg/m2 increase in BMI in studies fulfilling broad inclu-
sion criteria by use of the method of generalized least-
squares for trend estimation [13]; the value assigned to
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ies, 18 for underweight, and 35 for obesity, with the last
two values taken from a previous paper [14] because of
the impossibility of calculating means or medians for the
study populations.
In accordance with the Cochrane Collaboration Guide-
lines for systematic reviews [15], we assessed the clinical,
methodological, and statistical heterogeneity of the in-
cluded studies. Clinical heterogeneity was assessed by
evaluating differences in the study populations, exposures,
and outcomes. Methodological heterogeneity was assessed
by comparing the differences among the adjusted models.
Statistical heterogeneity was assessed using the I2 statistic
[15]. We performed a sensitivity analysis to quantify the
effect of each of the included studies (through a “leave-
one-out” method) and of low quality studies (not fulfilling
three quality criteria) on the overall results. Analyses were
carried out with R software [16] using the meta [17] and
metafor [18] packages.
Results
The electronic database search retrieved 2,022 records.
Additional file 1 displays the review process. After
reviewing titles and abstracts we identified 41 eligible
papers for full-text review. The manual search retrieved
5 further papers. Thirty-one studies [6,14,19-47] were
excluded: 6 of them [14,19-23] did not define or assess
the variables of interest; 21 studies [6,24-43] did not re-
port extractable data on the variables of interest; 1 study
[44] included only adolescents; 1 [45] did not define
obesity by means of BMI categories; 1 [46] reported data
only on migraine subtypes; 1 [47] had a design which
rendered its data incomparable with the other studies.
Four studies [48-51] fulfilled broad but not narrow in-
clusion criteria: 3 of them [48-50] had BMI categories
different from the WHO standards, while 1 [51] took
BMI categories from the WHO standards for Asian
people. We finally included 11 studies in the pooled ana-
lyses according to narrow criteria [52-62] and 15 studies
according to broad criteria [48-62].
Study characteristics
Table 1 displays the characteristics of the studies fulfilling
narrow inclusion criteria, while Table 2 describes those
fulfilling only broad inclusion criteria. One of the studies
[62] had a cohort design, investigated an exclusively
female population, and had BMI category as the
outcome. Among the 14 cross-sectional studies, thirteen
[48-54,56-61] had migraine as the outcome and BMI cat-
egories as the exposure; three of those studies [49,57,61]
included women only, eight [48,50,51,53,54,56,59,60] re-
ported the overall results for both men and women, and
three [52,56,58] reported their results according to gender.
One of the cross-sectional studies [55] had BMI categoryas the outcome and migraine as the exposure and did not
report separate results according to gender.
Risk of having migraine in obese subjects
Five cross-sectional studies fulfilling the narrow inclu-
sion criteria [54,56,59-61] investigated the risk of having
migraine in obese subjects as compared with normal
weight subjects. Two studies [59,61] found a significant
association between the two variables, while the other
three [54,56,60] did not find any association. Regarding
women, two studies [59,61] found an increased risk of
having any migraine in obese as compared with normal
weight women while another study [56] did not find any
association. In men, no increase was found in the risk of
having any migraine in obese subjects as compared with
normal weight subjects [56,59]. The pooled analysis did
not suggest an increased risk of having migraine in obese
as compared with normal weight subjects overall (PAEE
1.18; 95% CI, 0.99-1.41; P = 0.066), with substantial statis-
tical heterogeneity (I2 = 75.3%; P = 0.003) (Figure 1). In
obese women, the risk of having migraine was increased
(PAEE 1.44; 95% CI, 1.05-1.97; P = 0.023), with substantial
statistical heterogeneity (I2 = 78.0%; P = 0.011) (Figure 2),
while the same risk was not increased in obese men (PAEE
1.04; 95% CI, 0.86-1.25; P = 0.715), with no statistical het-
erogeneity (I2 = 0%; P = 0.350) (Additional file 2).
Two additional cross-sectional studies fulfilling narrow
inclusion criteria [57,58] defined obesity as a dichotom-
ous variable with a BMI cut-off of 30 kg/m2. One of the
studies [58] found an increased risk of having migraine
only in obese subjects aged 55 years or less and no in-
creased risk in obese subjects aged over 55 years, as
compared with non-obese subjects. The other study
[57], which was conducted in women aged 40 to 74
years, did not find any risk. The pooled analysis did not
suggest an increased risk of having migraine in obese as
compared with non-obese subjects (PAEE 1.11; 95% CI,
0.89-1.39; P = 0.365), with substantial statistical hetero-
geneity (I2 = 81.7%; P = 0.0002) (Additional file 2).
Four additional studies [48,49,51,52] met broad inclu-
sion criteria; among them, only one [51] found an in-
creased risk of having migraine in obese compared with
normal weight subjects. The pooled analysis including
those studies suggested an increased risk of having mi-
graine in obese compared with normal weight subjects
(PAEE 1.14; 95% CI, 1.02-1.27; P = 0.017), with moderate
statistical heterogeneity (I2 = 63.3%; P for Q test = 0.002).
Risk of having migraine in pre-obese subjects
Six cross-sectional studies fulfilling narrow inclusion cri-
teria, in seven cohorts [52,54,56,59-61], investigated the
risk of having migraine in pre-obese as compared with
normal weight subjects. One study [56] found a de-
creased risk of having migraine in pre-obese subjects
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Table 1 Main characteristics of the studies fulfilling narrow inclusion criteria (definition of body ass index categories according to the World Health
Organization criteria) (Continued)
Le, 2011 [56] Denmark Cross-sectional
(DTR)
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*baseline cross-sectional analysis of a cohort study.
BMI, body mass index; DTR, Danish Twin registry; ELSA, Longitudinal Study of Adult Health; HR, hazard ratio; NCS-R, National Comorbidity Survey Replication; NHANES, National Health And Nutrition Examination Survey;
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*baseline cross-sectional analysis of a cohort study.
†the authors of that paper used the terms “obesity” and “morbid obesity” to define BMI 25.0-29.9 kg/m2 and BMI≥30 kg/m2, respectively; we used BMI-based definitions instead of the given ones.
















Figure 1 Forest plots of the risk of having any migraine in obese, pre-obese, or underweight vs. normal weight subjects in studies fulfilling
narrow inclusion criteria.
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crease in the risk. In women, one study [59] found an in-
creased risk of having migraine in pre-obese as compared
with normal weight women, while three studies [52,56,61]did not find an increase in the same risk. In men, one
study [56] found a decrease in the same risk while two
other studies [52,58] did not find any risk. The pooled
analysis did not suggest an increased risk of having
Figure 2 Funnel plots of the risk of having any migraine in obese vs. normal weight women in studies fulfilling narrow inclusion criteria.
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jects (PAEE 0.98; 95% CI, 0.87-1.11; P = 0.767), with sub-
stantial statistical heterogeneity (I2 = 71.7%; P = 0.002)
(Figure 1). In pre-obese women, the risk of having migraine
was not increased (PAEE 1.08; 95% CI, 0.93-1.24; P = 0.308),
with moderate statistical heterogeneity (I2 = 42.4%;
P = 0.157), while in pre-obese men the risk was decreased
(PAEE 0.90; 95% CI, 0.81-1.00; P = 0.040), without statis-
tical heterogeneity (I2 = 0%; P = 0.409) (Additional file 2).
Three additional studies [48,50,51] met broad inclusion
criteria; none of them found an increased risk of having mi-
graine in pre-obese compared with normal weight subjects.
The pooled analysis including those studies confirmed the
non-increased risk of having migraine in pre-obese com-
pared with normal weight subjects (PAEE 0.99; 95% CI,
0.89-1.10; P = 0.870), with moderate statistical heterogeneity
(I2 = 66.0%; P for Q test = 0.001).
Risk of having migraine in underweight subjects
Five cross-sectional studies fulfilling narrow inclusion
criteria, in six cohorts [52,54,56,59,61], investigated the
risk of having migraine in underweight as compared
with normal weight subjects. One [56] of the four stud-
ies [54,56,59,61] reporting the result for the overall
population found a significant association between the
two variables, while the other three studies [54,59,61]
did not find any association. Four studies reported the
results by gender [52,56,59,61]. One of them [52] found
an increased risk of having any migraine in underweight
as compared with normal weight women, while the
others [56,59,61] did not find any increased risk. In
men, no increase was found in the risk of having any
migraine in underweight as compared with normal
weight men [52,56]. The pooled analysis suggested an
increased risk of having migraine in underweight as
compared with normal weight subjects (PAEE 1.21;95% CI, 1.07-1.37; P = 0.002), without statistical het-
erogeneity (I2 = 0%; P = 0.512) (Figure 1). The risk of
having migraine in underweight women (PAEE 1.15;
95% CI, 0.97-1.36; P = 0.101) or men (PAEE 1.15; 95%
CI, 0.75-1.76; P = 0.529) was not increased, with low
(I2 = 17.7%; P = 0.303) and absent (I2 = 0%; P = 0.843)
statistical heterogeneity, respectively (Additional file 2).
One additional study [51] met broad inclusion criteria;
that study did not find an increased risk of having mi-
graine in underweight compared with normal weight
subjects. The pooled analysis including that study con-
firmed the increased risk of having migraine in under-
weight compared with normal weight subjects (PAEE
1.21; 95% CI, 1.08-1.37; P = 0.017), with moderate statis-
tical heterogeneity (I2 = 63.3%; P for Q test = 0.002).Risk of having chronic migraine according to BMI status
Two cross-sectional studies fulfilling narrow inclusion
criteria [53,60] investigated the risk of having chronic
migraine in pre-obese as compared with normal weight
subjects. One of the two studies [53] found an increased
risk of having chronic migraine in pre-obese subjects,
while the other [60] did not find any risk. The pooled
analysis suggested an increased risk of having chronic mi-
graine in pre-obese as compared with normal weight sub-
jects (PAEE 1.39; 95% CI, 1.13-1.71; P = 0.002), without
statistical heterogeneity (I2 = 0%; P = 0.901) (Figure 3).
Those same two studies [53,60] investigated the risk of
having chronic migraine in obese as compared with nor-
mal weight subjects; however, one of the two studies [53]
only fulfilled broad inclusion criteria. The pooled analysis
suggested an increased risk of having chronic migraine in
obese compared with normal weight subjects (PAEE 1.75;
95% CI, 1.33-2.29; P < 0.001), without statistical hetero-
geneity (I2 = 0%; P for Q test = 0.770) (Figure 3).
Figure 3 Funnel plots of the risk of having chronic migraine in pre-obese vs. normal weight subjects in studies fulfilling narrow
inclusion criteria.
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One prospective cohort [62] and one cross-sectional
study [55] fulfilling narrow inclusion criteria investi-
gated the risk of being obese in migraineurs as com-
pared with non-migraineurs. The former [62] did not
find any association between migraine and obesity while
the latter [55] found an increased risk of being obese in
migraineurs.
The pooled analysis did not suggest an increased risk
of being obese in migraineurs as compared with non-
migraineurs (PAEE 1.28; 95% CI, 0.74-2.21; P = 0.374),
with substantial statistical heterogeneity (I2 = 82.8%;
P = 0.016) (Additional file 2).Linear analysis
Linear analysis performed using the generalized least-
squares method on the studies fulfilling broad inclusion
criteria showed that the effect size associated with every
5 kg/m2 increase in BMI was 0.993 (95% CI, 0.934-
1.056, P = 0.818), with substantial statistical heterogen-
eity (I2 = 66.6%; P < 0.001).Sensitivity analyses
The “leave-one-out” analysis revealed no substantial
changes after the exclusion of each study from the
pooled analyses in terms of the risk of having migraine
in underweight or pre-obese subjects as compared with
normal weight subjects, while the risk of migraine in
obese as compared with normal weight subjects became
significant after the exclusion of one study [56] from the
pooled analysis (data not shown).
None of the cross-sectional studies fulfilling narrow
inclusion criteria was of low quality according to the
NOS; therefore, we did not perform sensitivity analyses
based on study quality. On the contrary, the included
cohort study [62] did not fulfill three of the NOS criteria
(see Additional file 3), indicating a high risk of bias;
however, we could not perform sensitivity analyses with
the exclusion of that study because it was included in a
pooled analysis with only one other study.
Discussion
When including observational studies reporting the stand-
ard WHO BMI categories, our meta-analysis suggested
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was increased by about one fifth as compared with normal
weight subjects; the risk was increased also in obese as
compared with normal weight women, while it was de-
creased in pre-obese as compared with normal weight
men. When including studies with different BMI cut-offs
(broad inclusion criteria), we additionally found a slightly
increased risk of having migraine in obese as compared
with normal weight subjects. Notably, one of the add-
itional studies was performed in a female population [49],
while the other [48,50,51] investigated populations with
more women than men; therefore, in the pooled analysis a
specific effect of obesity on female migraineurs may have
been more evident. Together with age and attack fre-
quency, gender is one of the factors potentially modifying
the association between migraine and body weight; regret-
tably, only a minority of the available studies adequately
consider those factors, and with inconsistent results. Data
about possible gender differences are also scarce in our
meta-analysis, since several studies did not report separate
analyses by gender [48,50,54,55,60]. Additionally, as mi-
graine is more frequent in women than in men, studies
performed in men may be underpowered to detect any
significant association.
Age may be another important factor influencing the
effect of obesity on migraine: studies performed in youn-
ger subjects [58,59,61] found an increased risk of mi-
graine in obese subjects, while no association was found
between obesity and migraine in older subjects [57,58].
The negative results reported on the association between
migraine and obesity by most studies were attributed to
the inclusion of subjects of different ages, and to the
possible role of pre-menopausal hormonal status in con-
tributing to the association [58,59,61]. Patterns of mi-
graine activity, which is maximal in young adults and
declines after the age of 40 [63], could be another factor
influencing the association.
We found a markedly increased risk of chronic mi-
graine in overweight subjects as compared with normal
weight subjects. The finding of an increased risk of hav-
ing chronic migraine in pre-obese as compared with
normal weight subjects, though taken from the pooled
analysis of only two studies [53,60], had no statistical
heterogeneity. Moreover, the pooled analysis of those
same studies, which had different BMI cut-offs for obes-
ity, showed an even more remarkable increased risk of
chronic migraine in obese compared with normal weight
subjects. Some studies have also found an association
between obesity and chronic daily headache [64] or fre-
quent headaches [14], suggesting that increased body
weight is a risk factor for chronification of non-migraine
headaches; however, evidence suggests that this is not
valid for chronification of tension-type headaches [6,52],
while other data suggest that frequent intake of acutepain drugs may also have a role in migraine chronifica-
tion [47]. Therefore, although an association between
chronic migraine and body weight may exist, it is un-
clear whether that association is direct or mediated by
other factors.
Some studies support an association between pre-
obesity or obesity and increased attack frequency or
chronic migraine [6,49,62]. Notably, among them, a large
cross-sectional study found a higher migraine frequency
in underweight, pre-obese, and obese as compared with
normal weight subjects; the association was more evi-
dent, according to the authors, for daily migraine [49].
In a prospective follow-up of the same cohort [62],
higher migraine frequency was not associated with the
development of overweight or obesity suggesting that
obesity may favor migraine chronification while the in-
verse relationship is not valid. However, other studies
did not show any association between migraine fre-
quency and obesity [29,59,61].
While several studies are available to examine the risk
of having migraine in obese or pre-obese subjects, fewer
studies [45,46,55,62] have assessed the risk of being pre-
obese or obese in migraineurs as compared with non-
migraineurs. Two such studies [45,46] were excluded
from the analyses; one of those two studies [45] did not
find an increased risk of obesity in migraineurs as com-
pared with non-migraineurs, while the other [46] found
an increased risk of migraine with and without aura in
obese as compared with non-overweight subjects.
As recommended by the Cochrane Collaboration, the
eligibility criteria for a meta-analysis should be suffi-
ciently broad to encompass the likely diversity of studies,
but sufficiently narrow to ensure that a meaningful an-
swer can be obtained when studies are considered in ag-
gregate [15]. We performed our primary analyses only
on studies with uniform BMI cut-offs (narrow criteria)
in order to reduce between-studies heterogeneity; how-
ever, those analyses may have excluded too many stud-
ies; therefore, we performed additional analyses with
broad inclusion criteria.
The studies excluded from our analyses because they
included headaches other than migraine as an outcome
[14,19-22] found either a linear association between BMI
and the risk of having headache [14,21] or an association
between underweight [19] or obesity [19,22], but not
pre-obesity, and the risk of having headache. However,
in one study [20] the risk of having headache in under-
weight or obese compared with normal weight subjects
became non-significant in multivariate analyses. Taken
together, those findings suggest that non-migrainous
headaches are more influenced by body weight than mi-
graine. Several considerations led us to exclude headache
disorders other than migraine from the analyses. Firstly,
some headache disorders, such as idiopathic intracranial
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with obesity [65]; therefore, a positive association between
headache and obesity would likely have been driven by
those specific disorders. Secondly, previous studies have
shown that migraine and tension-type headache have dif-
ferent patterns of association with body weight [53].
Thirdly, migraine and obesity are both associated with in-
creased risk of vascular diseases [66], which adds interest
to the investigation of their association.
The worsening of migraine induced by obesity may
have an inflammatory origin. Adipocytes release adipo-
cytokines, and particularly adiponectin, which induces a
pro-inflammatory state and may activate the nitric oxide
pathway in the brain, thus causing or worsening head-
ache disorders [67]. Markers of oxidative stress and
metabolic risk such as nitrates and oxidized low-density
lipoproteins have been found to be increased in migrai-
neurs as compared with non-migraineurs [68] and may
represent a molecular link between migraine and obesity
[69]. Several studies have assessed the levels of adipocy-
tokines in subjects with migraine, with conflicting results
[70]. The adipose tissue releases proinflammatory cyto-
kines such as tumor necrosis factor alpha (TNFα), inter-
leukin (IL)-1, and IL-6, whose levels were also increased
in migraineurs [71]. Chronic inflammatory states have
been found in the metabolic syndrome, of which obesity
is part [72], and an increased risk of metabolic syndrome
was found in migraineurs as compared with non-
migraineurs [37], potentially explaining the associations
between migraine, obesity, and overall vascular risk.
In the association between migraine and underweight,
psychiatric comorbidities such as anxiety and depression
could act as potential confounders [73]; psychiatric co-
morbidities could also influence the relationship between
migraine and obesity [74]. Moreover, in the subgroup ana-
lyses by gender we did not find any association between
migraine and underweight either in men or in women,
suggesting the possibility of a spurious interaction in the
overall population.
To the best of our knowledge, this is the first quantita-
tive assessment of the associations between obesity, pre-
obesity or underweight, and migraine. The studies in-
cluded in the analyses were of good average quality and
investigated large populations.
Nonetheless, several issues should be raised. The exclu-
sion of non-English studies may have introduced bias, al-
though when reviewing titles and abstracts of retrieved
studies we did not find any study in a non-English language
fulfilling all the other inclusion criteria. In addition, despite
the numerous available data only a few studies considered
homogeneous BMI categories that could be included in the
pooled analyses. The included studies had important
sources of clinical heterogeneity (differences in age range
and gender distribution of the included subjects) andmethodological heterogeneity (confounders, definitions of
migraine). The identification of migraine subtypes was re-
ported in only three of the retrieved studies [46,56,62] and
these had different designs (cross-sectional and cohort) and
BMI category definitions, so could not be included in a
pooled analysis. In most cases migraine was self-reported,
thus potentially introducing a recall bias. The available
studies did not consider the effect on weight gain of pre-
ventive migraine agents usually prescribed in case of high
headache frequency [75]. The utilization of these drugs
may partly explain the association between high headache
frequency and obesity. Finally, BMI does not take into ac-
count the difference between lean and fat body mass.
Therefore, care must be taken not to classify a healthy,
muscular individual with very low body fat as overweight or
obese using the BMI formula. Other parameters, such as
abdominal obesity, may be more informative on the real
metabolic status of a subject, and may have a different dis-
tribution pattern in the general population than BMI [76].
Conclusions
Our meta-analysis of observational studies suggests an
association between migraine and obesity likely condi-
tioned by female gender. Evidence also suggests that
pre-obesity or obesity are risk factors for frequent or
chronic migraine. Further research should take into ac-
count potential modifiers of the association between mi-
graine and body weight such as gender, age, migraine
characteristics (duration, frequency, activity, severity,
and disability), together with migraine diagnostic criteria
and potential confounders such as medication intake
and migraine comorbidities. The association between
migraine and body weight has potential clinical implica-
tions; as suggested by the available data, body weight
management could be relevant for prevention of mi-
graine chronification and for improving the availability
of alternative treatment options.
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